Benjamin F. Edwards & Company’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$165K Sell
9,431
-1,500
-14% -$25K ﹤0.01% 963
2024
Q1
$184K Sell
10,931
-3,172
-22% -$54.1K ﹤0.01% 933
2023
Q4
$234K Sell
14,103
-20,950
-60% -$322K ﹤0.01% 835
2023
Q3
$545K Buy
35,053
+2,450
+8% +$40.9K 0.02% 499
2023
Q2
$556K Buy
32,603
+850
+3% +$14.7K 0.02% 477
2023
Q1
$560K Buy
31,753
+3,283
+12% +$59.7K 0.02% 462
2022
Q4
$512K Buy
28,470
+570
+2% +$10.6K 0.02% 460
2022
Q3
$482K Buy
27,900
+20,000
+253% +$382K 0.02% 442
2022
Q2
$148K Buy
+7,900
New +$156K 0.01% 751
2017
Q1
Sell
-3
Closed 1361
2016
Q4
$0 Buy
+3
New +$67 ﹤0.01% 1253

Other funds holding HQH

Benjamin F. Edwards & Company's HQH Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its abrdn Healthcare Investors (HQH) stake by 14% in Q2 2024, selling an estimated $25K and leaving 9,431 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Benjamin F. Edwards & Company first reported a position in HQH in Q4 2016 and has held it in 10 quarters since. The position peaked at $560K in Q1 2023. 113 funds tracked by Wall St. Rank hold HQH as of Q2 2024.

  • Benjamin F. Edwards & Company held 9,431 shares of abrdn Healthcare Investors worth $165K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 1,500 abrdn Healthcare Investors shares in Q2 2024, an estimated $25K.
  • abrdn Healthcare Investors made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #963 holding.
  • Benjamin F. Edwards & Company first reported a position in abrdn Healthcare Investors in Q4 2016 and has held it in 10 quarters since.
  • Benjamin F. Edwards & Company's abrdn Healthcare Investors position peaked at $560K in Q1 2023.
  • 113 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.